Search

everythinglearnresearchcommunity

for

Search:↓

A combination of cyclosporine and oral corticosteroid successfully regrew hair in a 19-year-old with alopecia universalis.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

A single steroid injection can cause serious side effects like Cushing Syndrome.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Treatment with dapsone, topical corticosteroids, and antibiotics improved the man's skin conditions.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Incorrect injection of corticosteroids for alopecia areata can cause skin problems.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Intralesional vitamin D3 injections can improve vitamin D3 levels and may help treat alopecia areata.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Baricitinib may effectively treat oral lichen planus.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

A patient lost all their hair while on rheumatoid arthritis medication.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

The child was diagnosed with a skin condition involving inflamed hair follicles.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.